These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19035297)

  • 1. PGP9.5 methylation as a marker for metastatic colorectal cancer.
    Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2008; 28(5A):2697-700. PubMed ID: 19035297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGP9.5 was less frequently methylated in advanced gastric carcinoma.
    Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Hepatogastroenterology; 2009; 56(94-95):1576-9. PubMed ID: 19950834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
    Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
    Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
    Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGP9.5 as a marker for invasive colorectal cancer.
    Yamazaki T; Hibi K; Takase T; Tezel E; Nakayama H; Kasai Y; Ito K; Akiyama S; Nagasaka T; Nakao A
    Clin Cancer Res; 2002 Jan; 8(1):192-5. PubMed ID: 11801558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.
    Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin methylation as a marker for advanced colorectal carcinoma.
    Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
    Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
    Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
    Brait M; Maldonado L; Noordhuis MG; Begum S; Loyo M; Poeta ML; Barbosa A; Fazio VM; Angioli R; Rabitti C; Marchionni L; de Graeff P; van der Zee AG; Wisman GB; Sidransky D; Hoque MO
    PLoS One; 2013; 8(9):e70878. PubMed ID: 24086249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
    Fukutomi S; Seki N; Koda K; Miyazaki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of HACE1 in gastric carcinoma.
    Sakata M; Kitamura YH; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jun; 29(6):2231-3. PubMed ID: 19528486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
    Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.
    Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Yokomizo K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers.
    Hibi K; Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2009; 56(93):1007-9. PubMed ID: 19760930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
    Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
    Okochi-Takada E; Nakazawa K; Wakabayashi M; Mori A; Ichimura S; Yasugi T; Ushijima T
    Int J Cancer; 2006 Sep; 119(6):1338-44. PubMed ID: 16642472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.